Phase II study of 131I-MIBG with vincristine and 5 days of irinotecan for patients with relapsed or refractory neuroblastoma.
Steven G. DuBois
No relevant relationships to disclose
M. Shelly Allen
No relevant relationships to disclose
Melissa Bent
No relevant relationships to disclose
Joan Hilton
No relevant relationships to disclose
Fabienne Hollinger
No relevant relationships to disclose
Jesse Courtier
No relevant relationships to disclose
Randall Hawkins
No relevant relationships to disclose
Yael P. Mosse
No relevant relationships to disclose
Katherine K. Matthay
Consultant or Advisory Role - Jubilant Draximage (U)